Novanta Inc. (NOVT): Price and Financial Metrics

Novanta Inc. (NOVT): $135.68

1.55 (+1.16%)

POWR Rating

Component Grades














  • Stability is the dimension where NOVT ranks best; there it ranks ahead of 96.4% of US stocks.
  • The strongest trend for NOVT is in Growth, which has been heading down over the past 206 days.
  • NOVT ranks lowest in Value; there it ranks in the 12th percentile.

NOVT Stock Summary

  • With a price/earnings ratio of 105.66, Novanta Inc P/E ratio is greater than that of about 92.66% of stocks in our set with positive earnings.
  • Price to trailing twelve month operating cash flow for NOVT is currently 31.81, higher than 85.31% of US stocks with positive operating cash flow.
  • The volatility of Novanta Inc's share price is greater than that of just 17.04% US stocks with at least 200 days of trading history.
  • If you're looking for stocks that are quantitatively similar to Novanta Inc, a group of peers worth examining would be SAIL, JKHY, EPRT, PBH, and VSAT.
  • NOVT's SEC filings can be seen here. And to visit Novanta Inc's official web site, go to

NOVT Price Target

For more insight on analysts targets of NOVT, see our NOVT price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $124.00 Average Broker Recommendation 1.88 (Hold)

NOVT Stock Price Chart Interactive Chart >

Price chart for NOVT

NOVT Price/Volume Stats

Current price $135.68 52-week high $146.16
Prev. close $134.13 52-week low $93.94
Day low $132.78 Volume 128,700
Day high $136.00 Avg. volume 106,153
50-day MA $132.22 Dividend yield N/A
200-day MA $121.75 Market Cap 4.80B

Novanta Inc. (NOVT) Company Bio

Novanta Inc. designs, develops, manufactures, and sells precision photonic and motion control components, and subsystems to original equipment manufacturers in the medical equipment and advanced industrial technology markets. The company operates through three segments: Laser Products, Vision Technologies, and Precision Motion. The company was founded in 1968 and is based in Bedford, Massachusetts.

NOVT Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$135.68$83 -35%

We started the process of determining a valid price forecast for Novanta Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Novanta Inc ranked in the 44th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 35%. The most interesting components of our discounted cash flow analysis for Novanta Inc ended up being:

  • The compound growth rate in the free cash flow of Novanta Inc over the past 5.58 years is 0.29%; that's better than 62.16% of cash flow producing equities in the Technology sector, where it is classified.
  • 95% of the company's capital comes from equity, which is greater than 81.18% of stocks in our cash flow based forecasting set.
  • The business' balance sheet reveals debt to be 5% of the company's capital (with equity being the remaining amount). Approximately just 18.78% of US stocks with free cash flow have a lower reliance on debt in their capital structure.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

ADBE, EXTR, RMBS, AVNW, and AVT can be thought of as valuation peers to NOVT, in the sense that they are in the Technology sector and have a similar price forecast based on DCF valuation.

NOVT Latest News Stream

Event/Time News Detail
Loading, please wait...

NOVT Latest Social Stream

Loading social stream, please wait...

View Full NOVT Social Stream

Latest NOVT News From Around the Web

Below are the latest news stories about Novanta Inc that investors may wish to consider to help them evaluate NOVT as an investment opportunity.

Company News for May 12, 2021

Companies in the news are: NOVT, IGT, FOE, BSY

Yahoo | May 12, 2021

We Think The Compensation For Novanta Inc.'s (NASDAQ:NOVT) CEO Looks About Right

CEO Matthijs Glastra has done a decent job of delivering relatively good performance at Novanta Inc. ( NASDAQ:NOVT...

Yahoo | May 7, 2021

Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, May 11, 2021

Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its first quarter 2021 results on Tuesday, May 11, 2021.

Yahoo | April 15, 2021

Be Wary Of Novanta (NASDAQ:NOVT) And Its Returns On Capital

What are the early trends we should look for to identify a stock that could multiply in value over the long term? In a...

Yahoo | April 9, 2021

Matthijs Glastra Appointed Chairman of the Board of Directors of Novanta Inc.

Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that its Board of Directors has appointed Matthijs Glastra, currently Chief Executive Office, to the additional role of Chairman of the Board, effective after the Company’s Annual Meeting of Shareholders on May 13, 2021. Mr. Glastra will succeed Stephen W. Bershad, who after a highly successful eleven year tenure, will retire from the Board and will not stand for re-election at Novanta’s Annual Meeting.

Yahoo | March 23, 2021

Read More 'NOVT' Stories Here

NOVT Price Returns

1-mo 0.01%
3-mo -5.67%
6-mo 19.87%
1-year 48.64%
3-year 114.01%
5-year 808.17%
YTD 14.77%
2020 33.67%
2019 40.38%
2018 26.00%
2017 138.10%
2016 54.19%

Continue Researching NOVT

Want to see what other sources are saying about Novanta Inc's financials and stock price? Try the links below:

Novanta Inc (NOVT) Stock Price | Nasdaq
Novanta Inc (NOVT) Stock Quote, History and News - Yahoo Finance
Novanta Inc (NOVT) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 1.099 seconds.